[1] Huang Wen Si, Xu Feng Mei, Zeng Qing Zhong, et al. ERK1/2-mediated Cytoplasmic Accumulation of hnRNPK Antagonizes TRAIL-induced Apoptosis through Upregulation of XIAP in H1299 Cells. Biomed Environ Sci, 2017; 30, 473-81. http://www.wanfangdata.com.cn/details/detail.do?_type=perio&id=bes201707001
[2] Radeva MY, Kugelmann D, Spindler V, et al. PKA compartmentalization via AKAP220 and AKAP12 contributes to endothelial barrier regulation. PLoS One, 2014; 9, e106733. doi:  10.1371/journal.pone.0106733
[3] Tsumura H, Satoh T, Ishiyama H, et al. Perioperative Search for Circulating Tumor Cells in Patients Undergoing Prostate Brachytherapy for Clinically Nonmetastatic Prostate Cancer. Int J Mol Sci, 2017; 18, S74. doi:  10.3390/ijms18010074
[4] Suren D, Yildirim M, Alikanoglu AS, et al. Lack of relation of AKAP12 with p53 and Bcl-2 in colorectal carcinoma. Asian Pac J Cancer Pre, 2014; 15, 3415-8. doi:  10.7314/APJCP.2014.15.8.3415
[5] Loke J, Assi S, Imperato M, et al. Identification of common and distinct epigeneticre programming properties of RUNX1 fusion proteins in acute myeloid leukaemia. Lancet, 2017; 89, S63. http://www.ncbi.nlm.nih.gov/pubmed/28114278
[6] Wei Xia, Jing Ni, Juhua Zhuang, et al. MiR-103 regulates hepatocellular carcinoma growth by targeting AKAP12. The Int J Biochem Cell Biol, 2016; 10, 1-11. http://www.wanfangdata.com.cn/details/detail.do?_type=perio&id=358fbc53e96da3ca5f0544fbac66582a
[7] Bozdogan Onder, Vargel Ibrahim, Cavusoglu Tarik, et al. Metastasis suppressor proteins in cutaneous squamous cell carcinoma. Pathol Res Pract, 2016; 212, 608-15. doi:  10.1016/j.prp.2015.12.018
[8] Hehnly H, Canton D, Bucko P, et al. A mitotic kinase scaffold depleted in testicular seminomas impacts spindle orientation in germ line stem cells. Elife, 2015; 4, e09384. doi:  10.7554/eLife.09384
[9] Han B, Poppinga WJ, Schmidt M. Scaffolding during the cell cycle by A-kinase anchoring proteins. Pflugers Arch, 2015; 467, 2401-11. doi:  10.1007/s00424-015-1718-0
[10] Muramatsu M, Gao L, Peresie J, et al. SSeCKS/AKAP12 scaffolding functions suppress B16F10-induced peritoneal metastasis by attenuating CXCL9/10 secretion by resident fibroblasts. Oncotarget, 2017; 8, 70281-98. http://europepmc.org/abstract/MED/29050279
[11] Irwin H Gelman. Suppression of Tumor and Metastasis Progression through the Scaffolding Functions of SSeCKS/Gravin/AKAP12. Cancer Metastasis Rev, 2012; 31, 493-500. doi:  10.1007/s10555-012-9360-1
[12] Reggi E, Diviani D. The role of A-kinase anchoring proteins in cancer development. Cellular Signalling, 2017; 40, 143-55. doi:  10.1016/j.cellsig.2017.09.011
[13] Peixoto P, Blomme A, Costanza B, et al. HDAC7 inhibition resets STAT3 tumorigenic activity in human glioblastoma independently of EGFR and PTEN:new opportunities for selected targeted therapies. Oncogene, 2016; 35, 4481-94. doi:  10.1038/onc.2015.506
[14] Tokoro T, Okuno K, Hida JC, et al. Prognostic factors for patients with advanced colorectal cancer and symptomatic brain metastases. Clin Colorectal Cancer, 2014; 4, 226-31. http://www.wanfangdata.com.cn/details/detail.do?_type=perio&id=0a5ea1f860e3e644ba973b74e308f167
[15] Xu G, Zhang M, Zhu H, et al. A 15-gene signature for prediction of colon cancer recurrence and prognosis based on SVM. Gene, 2017; 604, 33-40. doi:  10.1016/j.gene.2016.12.016
[16] Suren D, Yildirim M, Alikanoglu AS, et al. Lack of relation of AKAP12 with p53 and Bcl-2 in colorectal carcinoma. Asian Pac J Cancer Prev, 2014; 15, 3415-8. doi:  10.7314/APJCP.2014.15.8.3415
[17] Yildirim M, Suren D, Yildiz M, et al. AKAP12/Gravin gene expression in colorectal cancer:clinical importance and review of the literature. J BUON, 2013; 18, 635-40. http://www.ncbi.nlm.nih.gov/pubmed/24065476
[18] Jun-Mo Yang, Hye Shin Lee, Ji Hae Seo, et al. Structural environment built by AKAP12+ colon mesenchymal cells drives M2 macrophages during inflammation recovery. Sci Rep, 2017; 7, 42723. doi:  10.1038/srep42723
[19] Lee Hye Shin, Choi Jinhyeok, Son Taekwon, et al. Altered AKAP12 expression in portal fibroblasts and liver sinusoids mediates transition from hepatic fibrogenesis to fibrosis resolution. Exp Mol Med, 2018; 50, 48. doi:  10.1038/s12276-018-0074-5
[20] Liu ZJ, Liu W, Cui CH, et al. Association between A-kinase anchor proteins 12 methylation and recurrence of hepatocellular carcinoma. Chinese Journal of Preventive Medicine, 2017; 51, 848-52. (In Chinese) http://www.wanfangdata.com.cn/details/detail.do?_type=perio&id=zhyfyx201709017
[21] Lin ZY, Wu CC, Chuang YH, et al. Anti-cancer mechanisms of clinically acceptable colchicine concentrations on hepatocellular carcinoma. Life Sci, 2013; 93, 323-8. doi:  10.1016/j.lfs.2013.07.002
[22] Fonocho E, Aydin N, Reddy S, et al. Recurrent gastric cancer metastasizing to the bone marrow:A case report of a rare presentation. Int J Surg Case Rep, 2017; 37, 165-8. doi:  10.1016/j.ijscr.2017.06.025
[23] Choi MC, Jong HS, Kim TY, et al. AKAP12/Gravin is inactivated by epigenetic mechanism in huamn gastriccarcinoma and shows growth suppressor activity. Oncogene, 2004; 23, 7095-103. doi:  10.1038/sj.onc.1207932
[24] Thomas Wilhelm, Daniel B Lipka, Tania Witte, et al. Epigenetic silencing of akap12 in juvenile myelomonocytic leukemia. Epigenetics, 2016; 11, 110-9. doi:  10.1080/15592294.2016.1145327
[25] Yildirim Mustafa, Paydas Semra, Tanriverdi Kahraman, et al. Gravin gene expression in acute leukaemias:clinical importance and review of the literature. Leuk Lymphoma, 2007; 48, 1167-72. doi:  10.1080/10428190701377055
[26] Ko HK, Akakura S, Peresie J, et al. A transgenic mouse model for early prostate metastasis to lymph nodes. Cancer Res, 2014; 74, 945-53. doi:  10.1158/0008-5472.CAN-13-1157
[27] Marino N, Collins JW, Shen C, et al. Identification and validation of genes with expression patterns inverse to multiple metastasis suppressor genes in breast cancer cell lines. Clin Exp Metastasis, 2014; 31, 771-86. doi:  10.1007/s10585-014-9667-0
[28] Sun Y, Ye C, Guo X, et al. Evaluation of potential regulatory function of breast cancer risk locus at 6q25.1. Carcinogenesis, 2016; 37, 163-8. doi:  10.1093/carcin/bgv170
[29] Goeppert B, Schmidt CR, Geiselhart L, et al. Differential expression of the tumor suppressor A-kinase anchor protein 12 in human diffuse and pilocytic astrocytomas is regulated by promoter methylation. J Neuropathol Exp Neurol, 2013; 72, 933-41. doi:  10.1097/NEN.0b013e3182a59a88
[30] Serret Christina A, Wang Stephanie, Marsch Amanda, et al. Pigmented squamous cell carcinoma presenting as longitudinal melanonychia in a transplant recipient. Cutis, 2018; 101, 375-7. http://europepmc.org/abstract/MED/29894528
[31] Bozdogan Onder, Yulug Isik G, Vargel Ibrahim, et al. Differential expression patterns of metastasis suppressor proteins in basal cell carcinoma. Int J Dermatol, 2015; 54, 905-15. doi:  10.1111/ijd.2015.54.issue-8
[32] Jarrett SG, Wolf Horrell EM, D Orazio JA. AKAP12 mediates PKA-induced phosphory-lation of ATR to enhance nucleotide excision repair. Nucleic Acids Res, 2016; 44, 10711-26. doi:  10.1093/nar/gkw871
[33] Legastelois R, Jeanblanc J, Vilpoux C. Epigenetic mechanisms and alcohol use disorders:a potential therapeutic target. Biol Aujourdhui, 2017; 211, 83-91. doi:  10.1051/jbio/2017014
[34] Poppinga WJ, Muñoz-Llancao P, González-Billault C, et al. A-kinase anchoring proteins:cAMP compartmentalization in neurodegenerative and obstructive pulmonary diseases. Br J Pharmacol, 2014; 171, 5603-23. doi:  10.1111/bph.2014.171.issue-24
[35] Finger EC, Castellini L, Rankin EB, et al. Hypoxic induction of AKAP12 variant 2 shifts PKA-mediated protein phosphorylation to enhance migration and metastasis of melanoma cells. Proc Natl Acad Sci USA, 2015; 112; 4441-6. doi:  10.1073/pnas.1418164112